Abstract: Isatin-3-thiosemicarbazone complexes with Co(II), Ni(II), Cu(II), Zn(II), Hg(II) and Pd(II) were synthesized and evaluated for their antimicrobial activity against 7 pathogenic bacteria and 4 fungi. The complexes have an enhanced activity compared to the ligand due to transition metal involved in coordination. The anti-amoebic activity in vitro was evaluated against the HM1:IMSS strain of Entamoeba histolytica and the results were compared with the standard drug, metronidazole. The preliminary test results showed that the complexes had better anti-amoebic activity than their respective ligands. Moreover, the complexes showed better inhibition of the test organism.
INTRODUCTION
Thiosemicarbazones are of considerable interest because of their chemistry and potentially beneficial biological activities, such as antitumor, antibacterial, antiviral and antimalarial activities. 1, 2 Although thiosemicarbazones as ligands and their complexes are not unknown, there is not enough data about their antibacterial, antifungal and anti-amoebic activity. In the present study, the aim was to achieve a better biological profile at lower concentrations, by preparing and evaluating isatin-3-thiosemicarbazone and the corresponding complexes with Co(II), Ni(II), Cu(II), Zn(II), Hg(II) and Pd(II). EXPERIMENTAL 
Materials, methods and instruments
All chemicals used in the present work, viz., isatin, thiosemicarbazide, metal chlorides and solvents were of analytical reagent (A.R.) grade (E. Merck). 
General procedure for the preparation of isatin-3-thiosemicarbazone (ITC) and the complexes
Isatin-3-thiosemicarbazone (ITC) was prepared using a standard method. 3 The complexes were synthesized using the direct method between the ligand and the required metal(II) chloride (2:1 for Ni(II) Co(II)) and 1:1 molar ratio for Cu(II), Zn(II), Pd(II) and Hg(II). 3 The solutions were heated under reflux for 3-5 h and the products were filtered, washed with ethanol and dried in vacuo over CaCl 2 ( Fig. 1 
Analytical measurements
Microanalysis for carbon, hydrogen and nitrogen was carried with a Carlo Erba 1106 microanalyzer. The chloride content was determined potentiometrically. The metal contents were determined using a Virial AA-457 double beam spectrometer. The FTIR spectra were recorded on a Michaelson Bomen MB-series spectrophotometer, using the KBr pellet technique (1 mg/100 mg). The electronic spectra were recorded on a Perkin/Elmer Lambda 15 UV/Vis spectrophotometer using 10 -3 mol dm -3 solutions in DMF. The 1 H-NMR spectra were obtained in DMSO solution using a Gemini-200 "HF NMR" spectrometer. The magnetic susceptibility measurements were made at room temperature using an MSB-MKI magnetic balance (Sherwood Scientific Ltd.). The data were corrected for diamagnetism.
In vitro antibacterial, antifungal and anti-amoebic activity
The compounds were evaluated for their in vitro antibacterial activity against Escherichia coli, Staphylococcus aureus, Enterobacter sp., Proteus mirabilis, Bacillus anthracis, Pseudomonas aeruginosa and Streptococcus faecalis. The minimum inhibitory concentration (MIC) was assessed by the agar dilution method according to guidelines established by the NCCLS ISATIN-3-THIOSEMICARBAZONE COMPLEXES 9 standard M7-A5. 4 A series of different concentrations of the compounds with Mueller Hinton broth was inoculated and incubated at 37 °C for 24 h. The minimum inhibitory concentration (MIC, in µg cm -3 ) was considered to be the lowest concentration, which exhibited the same turbidity as the blank tube. The compounds were evaluated for their in vitro antifungal activity against Microsporum gypsum, Epidermophyton floccosum, Histoplasma capsulatum, Candida albicans and Aspergillus niger following the guidelines in the NCCLS document M27-A using the microdilution broth method. 5 The antifungal activities of the yeast were performed in RPMI 1640 medium as outlined in the document M27-A in DMF as solvent. The chemical compounds-broth medium serial tube dilutions inoculated with each yeast were incubated at 37 °C for 48-72 h. The anti-amoebic activities of the in vitro culture against the HM1:IMSS strain of Entamoeba histolytica was performed by the standard method. [6] [7] [8] [9] The E. histolytica strain HM1:IMSS was cultured using Diamond TYIS-33 medium. 8 All the compounds were dissolved in DMF whereby the maximum concentration of DMF did not exceed 0.1 %, at which level no inhibition of amoebae growth occurred. 9, 10 All the experiments were carried out in triplicate at each concentration level and repeated twice. The optical density of the resulting solution in each well was determined at 490 nm with a microplate reader. The per cent inhibition of amoebae growth was calculated from the optical densities of the control and test wells and plotted against the logarithm of the dose of the tested drug. Linear regression analysis was used to determine the best fitting straight line, from which the IC 50 value was found.
RESULTS AND DISCUSSION
The analytical data for the prepared ligand and complexes are given below. The complexes were evaluated for their in vitro antimicrobial activity against 7 pathogenic bacteria and 4 fungi. The data for metal(II) chlorides, sulfamethoxazole, trimethoprim and clotrimazole are included for comparison. All compounds have different antibacterial activity in vitro against the tested gram-positive and gram-negative bacteria as well as the fungi. The obtained results of the coordination compounds show enhanced activity compared to the ligand, which indicates that the coordinated metal have an influence on the anitimicrobial effects. Since all complexes are soluble in DMF, the different activities cannot be correlated with different solubility. However, the higher activity of the complexes, as compared to the free ligand, can be understood in terms of the chelation theory. This theory explains that a decrease in the polarizability of the metal could enhance the lipophilicity of the complexes. 10 The complexes with Hg(II), Pd(II) and Zn(II) were the most active against all the tested bacteria and fungi (Tables I and II) .
All the complexes showed a higher activity than sulfamethoxazole, but the ligand had the same activity against B. anthracis and E. coli and less activity against Enterobacter sp. All the compounds showed higher activity than trimethoprim against S. aureus, B. anthracis (except the ligand) and P. aeruginosa and lower activity against E. coli. The complex with Hg(II) showed better activity than trimethoprim against P. mirabilis (Zn(II) and Pd(II) complexes exhibited the same activity), while against S. faecalis, the Hg(II) and Pd(II) complexes exhibited higher activity, while the Zn(II) complex had the same activity as trimethoprim.
The antifungal activity of the compounds was studied against four pathogenic fungi (Table II) . Clortrimazole was used as the reference for inhibitory activity against fungi.
All the compounds showed a significant antifungal activity, especially the Hg(II) complex, against all the tested fungi. When compared to clotrimazole, Pd(II) exhibited higher activity against M. gypsum, while Zn(II) and Ni(II) complexes were equipotent against M. gypsum. The complexes with Co(II), Cu(II) and Pd(II) were equipotent against A. niger. The in vitro anti-amoebic activities of isatin-3-thiosemicarbazone and its complexes were tested using the HM1:IMSS strain of E. histolytica to ascertain the effectiveness of the metal complexes in comparison with their ligand. Metronidazole was used as the reference drug with an IC 50 1.8 µM and the results are given in Table III. The results were estimated as the percentage of growth inhibition compared with the inhibited controls and plotted as probate values as a function of the drug concentration. IC 50 and 95 % confidence limits were interpolated in the corresponding dose response curve. Complexing enhances the activity of the ligand, which may be due to chelation, which reduces the polarity of the central metal atom because of partial sharing of its positive charge with the ligand. The Co(II), Zn(II) and Pd(II) complexes were more active than metronidazole with smaller IC 50 values (1.44, 0.90 and 0.70 µM, respectively). The results were statistically evaluated by analysis of the variance. The null hypothesis was tested using the t-test. The significance of the difference between the IC 50 values of metronidazole and the complexes with Co(II), Zn(II) and Pd(II) was evaluated by the t-test. The calculated t values were found to be higher than the table value of t at the 5 % level. Thus it can be concluded that the character under study was significantly influenced by the treatment. Detailed studies of the toxicity of these compounds, mechanism of action as well as in vivo studies are in progress. 
